Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Optimizing Induction Therapy for High-Risk Nasopharyngeal Carcinoma.
Journal: NEJM evidence
Published: August 25, 2026
Recalibrating Dual Checkpoint Blockade? Lessons from Volrustomig.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2026
Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.
Journal: JAMA oncology
Published: September 25, 2025
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.
Journal: Cancer research communications
Published: September 24, 2025
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.
Journal: Cancer research communications
Published: September 24, 2025
Novel Therapeutic Development for Nasopharyngeal Carcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2025
Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial.
Journal: Nature communications
Published: April 25, 2025
Reversible downregulation of HLA class I in adenoid cystic carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 03, 2025
Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallenge.
Journal: The Journal of clinical investigation
Published: March 17, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.
Journal: NPJ precision oncology
Published: February 24, 2025
Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.
Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma.
Journal: Oncoimmunology
Published: February 18, 2025
Last Updated: 09/26/2026